Ikervis Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Ciclosporin

Indications/Uses

Severe keratitis in adult patients w/ dry eye disease. Severe vernal keratoconjunctivitis (VKC) in childn from 4 yr through adolescence.

Click to view Ikervis detailed prescribing information

Dosage/Direction for Use

Severe keratitis in dry eye disease Adult 1 drop once daily to affected eye(s) at bedtime. Reassess treatment at least every 6 mth. Severe VKC Childn from 4 yr 1 drop qds to affected eye(s), may be maintained or decreased to 1 drop bd once control is achieved. Reassess treatment at 4 mth.

Click to view Ikervis detailed prescribing information

Overdosage

View Ikervis overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Active or suspected ocular or peri-ocular infection. Ocular malignancies or premalignant conditions.

Click to view Ikervis detailed prescribing information

Special Precautions

History of ocular herpes, varicella-zoster, or vaccinia virus infection. Glaucoma; active orofacial herpes simplex infection. Remove contact lenses before instillation & reinsert at wake-up time. Administer at least 15 min apart if >1 topical ophth product is used. May cause eye irritation due to cetalkonium Cl. Perform regular eye exam every 3-6 mth if used >12 mth. Concomitant use w/ β-blockers & corticosteroids. May affect ability to drive & use machines. Not recommended in women of childbearing potential & during pregnancy. Lactation. Childn & adolescents <18 yr w/ severe keratitis; childn <4 yr & adults >18 yr w/ severe VKC.

Click to view Ikervis detailed prescribing information

Use In Pregnancy & Lactation

Click to view Ikervis detailed prescribing information

Adverse Reactions

Instillation site & eye pain. Eyelid erythema & oedema, increased lacrimation, ocular & conjunctival hyperaemia, blurred vision, reduced visual acuity, eye irritation, pain & pruritus; instillation site irritation, erythema & lacrimation, ocular discomfort, foreign body sensation in eyes; URTI; headache; cough.

Click to view Ikervis detailed prescribing information

Drug Interactions

Potentiated effects by corticosteroids.

Click to view Ikervis detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Ikervis detailed prescribing information

Storage

View Ikervis storage conditions for details to ensure optimal shelf-life.

Description

View Ikervis description for details of the chemical structure and excipients (inactive components).

Action

View Ikervis mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Ophthalmic Decongestants, Anesthetics, Anti-Inflammatories

ATC Classification

S01XA18 - ciclosporin ; Belongs to the class of other ophthalmologicals .

Regulatory Classification

Presentation/Packing

Form

Ikervis ophth emulsion 1 mg/mL

Packing/Price

0.3 mL x 30 × 1's

Ikervis

ciclosporin

Manufacturer:

Santen Pharma

Distributor:

Zuellig Pharma